跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,404 条关于
“MPS VI”
全部
3,404
临床试验
2,546
药物
387
机构
65
资讯
406
去年
Inventiva Files 2024 Half-Year Report, Advancing Lanifibranor for MASH/NASH Treatment
去年
Spruce Biosciences Acquires Tralesinidase Alfa for Sanfilippo Syndrome Type B Treatment with BLA Submission Planned for 2026
2年前
Denali Therapeutics Plans Accelerated Approval Filing for Tividenofusp Alfa in MPS II
去年
Ultragenyx's UX111 Gene Therapy Shows Promise in Sanfilippo Syndrome Type A
2个月前
FDA and Medtech Industry Agree on MDUFA VI Draft Commitment Letter with Faster Pre-Submission Pathway and Enhanced Performance Goals
去年
REGENXBIO and Nippon Shinyaku Partner to Advance Gene Therapies for MPS I and MPS II
去年
Regenxbio Expands MPS I Gene Therapy Trial After Initial Data Review
去年
Biosimilar Laronidase Shows Comparable Efficacy to Reference Drug in MPS I Patients
去年
Four Promising Gene and Cell Therapies Challenge Aldurazyme's Dominance in MPS I Treatment
去年
Immusoft's Engineered B-Cell Therapy Shows Promise in MPS I Trial
第 1 页,共 41 页
上一页
下一页